Stocktoria
MEDICINOVA INC MNOV
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2006-12-01
MEDICINOVA INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $409,657 | — | $1.0M | — | $4.0M |
| R&D expense | $6.7M | $6.8M | $5.3M | $8.7M | $8.1M |
| Operating income | -$13.3M | -$12.7M | -$9.9M | -$14.6M | -$10.2M |
| Income tax | $5,994 | $5,537 | $3,047 | $2,822 | $2,568 |
| Net income | -$12.0M | -$11.0M | -$8.6M | -$14.1M | -$10.1M |
| EPS (diluted) | $-0.24 | $-0.23 | $-0.17 | $-0.29 | $-0.21 |
| Operating cash flow | -$9.8M | -$10.6M | -$7.4M | -$12.9M | -$9.4M |
| Free cash flow | -$9.8M | -$10.6M | -$7.5M | -$12.9M | -$9.4M |
| Cash & equivalents | $30.8M | $40.4M | $51.0M | $18.5M | $71.4M |
| Total assets | $45.6M | $55.9M | $66.3M | $74.2M | $87.4M |
| Total liabilities | $4.0M | $3.4M | $3.9M | $3.9M | $3.7M |
| Shareholders' equity | $41.6M | $52.5M | $62.4M | $70.2M | $83.7M |
Source: SEC EDGAR filings · CIK 0001226616 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.